Great West Life Assurance CO Inhibrx, Inc. Transaction History

Great West Life Assurance CO

  • $53.1 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
BUY
$14.5 - $38.0 $24,809 - $65,018
1,711 Added 142.7%
2,910 $110,000
Q4 2022

Feb 10, 2023
BUY
$20.18 - $33.33 $10,836 - $17,898
537 Added 81.12%
1,199 $30,000
Q3 2022

Nov 01, 2022
BUY
$11.58 - $24.73 $7,665 - $16,371
662 New
662 $12,000
Q4 2020

Feb 16, 2021
BUY
$15.96 - $50.0 $10,565 - $33,100
662 New
662 $22,000

Others Institutions Holding INBX

# of Institutions
2
Shares Held
25.3K
Call Options Held
0
Put Options Held
0
View Full List

About Inhibrx, Inc.

INBX Quotes by TradingView
  • Ticker INBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,057,700
  • Market Cap $617M
  • Description
  • Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcin...
More about INBX
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email